Gentian Violet

DRUG2 trials

Sponsors

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Wake Forest University Health Sciences

Conditions

HIV-1 InfectionHidradenitis Suppurativa

Phase 2

Gentian Violet Treatment for Hidradenitis Suppurativa

WithdrawnNCT04388163

Wake Forest University Health SciencesHidradenitis Suppurativa

Start: 2025-08-31End: 2026-12-31Updated: 2025-09-04

Phase 3

Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

CompletedNCT01427738

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsHIV-1 Infection

Start: 2011-06-30End: 2014-01-31Updated: 2015-02-16